Second Line Treatment in Patients with Multiple Myeloma Progressing after Bortezomib, Lenalidomide, Dexamethasone Induction, Autologous Transplant and Lenalidomide MaintenanceOren Pasvolsky,Denai R. Milton,Mark R. Tanner,Qaiser Bashir,Samer A. Srour,Neeraj Y. Saini,Paul Lin, Umer R. Siddiqui,Hina N. Khan,Jeremy Ramdial,Yago Nieto,Guilin Tang, Kiran Lakhani, Yosra M. Aljawai,Partow Kebriaei,Hans C. Lee,Krina K. Patel,Sheeba K. Thomas,Robert Z. Orlowski,Elizabeth J. Shpall,Richard E. Champlin,Muzaffar H. QazilbashBLOOD(2024)引用 0|浏览2AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要